Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. notified the Company of his plans to retire in March 2027. The Company has initiated a search for a new Chief Financial Officer to ensure a smooth transition. Celldex Therapeutics, Inc. is a biotechnology company that develops clinical-stage drug candidates for the treatment of various oncology-related diseases.
